Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innospec (IOSP) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for Innospec (IOSP) over the last 12 years, with Q2 2025 value amounting to $166037.0.

  • Innospec's Gains from Investment Securities fell 7232.72% to $166037.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 261686.67%. This contributed to the annual value of $619705.0 for FY2024, which is 1169.48% down from last year.
  • Per Innospec's latest filing, its Gains from Investment Securities stood at $166037.0 for Q2 2025, which was down 7232.72% from $166037.0 recorded in Q1 2025.
  • In the past 5 years, Innospec's Gains from Investment Securities registered a high of $3.2 million during Q4 2024, and its lowest value of $135942.0 during Q1 2024.
  • Over the past 3 years, Innospec's median Gains from Investment Securities value was $166037.0 (recorded in 2025), while the average stood at $753200.1.
  • Data for Innospec's Gains from Investment Securities shows a peak YoY increase of 2213.81% (in 2025) and a maximum YoY decrease of 7232.72% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows Innospec's Gains from Investment Securities stood at $864518.0 in 2022, then surged by 270.15% to $3.2 million in 2024, then crashed by 94.81% to $166037.0 in 2025.
  • Its Gains from Investment Securities stands at $166037.0 for Q2 2025, versus $166037.0 for Q1 2025 and $3.2 million for Q4 2024.